Syneron Medical Ltd. (ELOS) to Acquire Assets of TransPharma Medical Ltd. for $3.6 Million
3/12/2012 7:37:44 AM
More...
|
TransPharma Medical Ltd. Announces Successful Completion of a Phase 1b Clinical Trial of ViaDor-GLP1 Agonist Indicated for the Treatment of Type II Diabetes
2/22/2011 10:05:04 AM
More...
|
TransPharma Medical Ltd. Changes the Name of Its Transdermal Drug Delivery System from ViaDerm to ViaDor™
1/17/2011 11:30:12 PM
More...
|
TransPharma Medical Ltd. Announces Successful Results of a Phase 1 Clinical Trial of ViaDerm-Calcitonin for the Treatment of Musculoskeletal Disorders
1/11/2011 9:39:13 AM
More...
|
TransPharma Medical Ltd. Announces Successful Results of a 4 Week Phase 1 Clinical Trial of Its New Self-applied ViaDerm System for the Treatment of Osteoporosis
10/26/2010 9:52:23 AM
More...
|
TransPharma Medical Ltd. Announces Successful Completion of Phase 1a Clinical Trial of ViaDerm-GLP1 Agonist Indicated for the Treatment of Type II Diabetes
9/14/2010 7:34:47 AM
More...
|
TransPharma Medical Ltd. Announces Successful Completion of Phase 2 Trial of ViaDerm-hPTH (1-34) in Postmenopausal Women with Osteoporosis
9/1/2009 10:29:39 AM
More...
|
TransPharma Medical Ltd. Receives European CE Mark Approval for its Transdermal Drug Delivery Device
12/15/2008 6:24:16 AM
More...
|
Frost & Sullivan Honours TransPharma Medical Ltd. for its Innovative ViaDerm Drug Delivery System
8/4/2008 9:36:09 AM
More...
|
Eli Lilly and Company (LLY) and TransPharma Medical Ltd. Announce Licensing and Development Agreement; TransPharma to Receive $35 Million
6/12/2008 6:19:41 AM
More...
|
|